(Q44994475)

8 December 2017

Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group (English)

1 reference

8 December 2017

0 references

1 reference

1 reference

1 reference

1 reference

H Peltola

1

1 reference

8 December 2017

M Anttila

series ordinal

2

1 reference

8 December 2017

O V Renkonen

series ordinal

3

1 reference

8 December 2017

language of work or name

English

0 references

publication date

1 June 1989

1 reference

8 December 2017

1 reference

8 December 2017

1

1 reference

8 December 2017

8650

1 reference

8 December 2017

1281-1287

1 reference

Empiric therapy for bacterial meningitis.

8 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Plasmid-mediated resistance in multiply resistant Haemophilus influenzae type b causing meningitis: molecular characterization of one strain and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Isolation of an ampicillin-resistant, non-beta-lactamase-producing strain of Haemophilus influenzae

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Ampicillin treatment failure of apparently beta-lactamase-negative Haemophilus influenzae type b meningitis due to novel beta-lactamase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Combined action of chloramphenicol and ampicillin on chloramphenicol-resistant Haemophilus influenzae

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Interactions among chloramphenicol, phenytoin, and phenobarbital in a pediatric patient

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Cefotaxime therapy of bacterial meningitis in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

A prospective randomized comparison of cefotaxime vs ampicillin and chloramphenicol for bacterial meningitis in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Cefotaxime vs. conventional therapy for the treatment of bacterial meningitis of infants and children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Comparison of ceftriaxone with standard therapy for bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Comparison of ceftriaxone and traditional therapy of bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Comparison of the efficacy and safety of ceftriaxone to ampicillin/ chloramphenicol in the treatment of childhood meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Prospective comparative trial of ceftriaxone vs. conventional therapy for treatment of bacterial meningitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Antibody response to capsular polysaccharides of groups A and C neisseria meningitidis and Haemophilus influenzae type b during bacteremic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

C-reactive protein for rapid monitoring of infections of the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Serum C-reactive protein as detector of pretreated childhood bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Cerebrospinal fluid lactic acid levels in meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Cerebrospinal fluid lactate and the diagnosis of meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Bacterial meningitis in children: diagnosis and therapy. A review of recent developments

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Bactericidal and Bacteriostatic Action of Chloramphenicol Against Meningeal Pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Oral chloramphenicol in the treatment of Haemophilus influenzae meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Antibiotic-resistant Streptococcus pneumoniae: clinical and epidemiologic aspects.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Emergence of Multiply Resistant Pneumococci

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Penetration of sulbactam-ampicillin and clavulanic acid-amoxicillin into the pelvic peritoneum

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Cost containment of reconstituted parenteral antibiotics: personnel and supply costs associated with preparation, dispensing, and administration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Outpatient treatment of serious infections in infants and children with ceftriaxone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Single injection treatment of meningococcal meningitis 1. Long-acting penicillin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Single injection treatment of meningococcal meningitis 2. Long-acting chloramphenicol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Four days of penicillin therapy for meningococcal meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

Treatment failures of cefotaxime and latamoxef in meningitis caused by Enterobacter and Serratia spp.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2889%2992685-8

7 January 2021

10.1016/S0140-6736(89)92685-8

Identifiers

DOI

1 reference

8 December 2017

1 reference